The Biopsy Decision Deserves Thought
After prostate cancer screening and further evaluation, some men reach a point where they and their clinician evaluate whether a prostate biopsy is the right next step. For many, this moment can feel like a crossroads—bringing relief that more information is available, but also uncertainty about whether taking the next step is truly necessary.
Importantly, deciding whether to have a biopsy is rarely urgent or automatic. It is a decision that deserves thoughtful consideration, guided by medical evidence, personal health factors, and individual comfort with uncertainty. At this stage, the question is no longer simply what might be happening, but whether the potential benefits of confirming a diagnosis through a biopsy outweigh the possible downsides for you and your medical team.
What a Prostate Biopsy Is — at a High Level
A prostate biopsy is a diagnostic test used to confirm whether prostate cancer is present and, if so, to better understand its characteristics. It is currently the only way to make a definitive diagnosis of prostate cancer.
At the same time, a biopsy is optional, not inevitable. Many men with elevated screening results or a higher estimated likelihood of aggressive disease never undergo biopsy, either because the likelihood of aggressive cancer appears low or because continued monitoring is a reasonable alternative. The purpose of discussing biopsy is not to pressure a decision, but to consider whether it is likely to provide information that meaningfully changes care.
Why Biopsy Is Not the Right Next Step for Everyone
One of the most important lessons learned over time is that not all prostate cancers require immediate detection or treatment. Some forms of prostate cancer grow so slowly that they are unlikely to cause symptoms or affect health, even over many years.
Because of this, performing a biopsy in every man with an elevated screening result would lead to the detection of cancers that may never cause harm. In these situations, the downsides of knowing—and potentially treating—such cancers may outweigh the benefits.
The goal of modern prostate cancer evaluation is not simply to find any cancer, but to identify cancers that are aggressive or clinically meaningful and may require treatment. This is why careful decision-making before a biopsy matters to you and your care team.
What Factors Go Into a Biopsy Decision
Deciding whether to proceed with a biopsy is a personalized process. There is no single result or number that determines the “right” choice for everyone. Instead, you and your clinicians consider a combination of factors, including:
- The estimated likelihood of aggressive prostate cancer
- Age and overall health
- Family history and prior test results
- How comfortable a person feels with uncertainty versus additional testing
Together, these considerations help frame whether biopsy is likely to provide useful information to help make an informed decision.
How Probability-Based Information Can Guide This Choice
Advances in prostate cancer evaluation have made it possible to estimate the likelihood of aggressive disease with greater precision than screening alone. Probability-based tools like the 4Kscore® Test provide context for atypical screening signals, such as an elevated PSA or abnormal DRE, by estimating the likelihood of finding aggressive cancer on a biopsy.
This information can be especially helpful when deciding whether—or when—to pursue biopsy. A lower estimated likelihood of aggressive disease may support continued monitoring, while a higher likelihood may suggest that additional clinical work up, including a potential biopsy, may be warranted.
Importantly, probability does not make the decision for you. Instead, it supports more informed conversations between you and your care team by clarifying trade-offs and helping align next steps with individual goals and preferences.
Choosing Biopsy or Choosing to Wait
Both proceeding with a biopsy and choosing to defer it are valid, active decisions.
Choosing biopsy may provide reassurance or clearer answers that help guide future care.
Choosing to wait may involve continued monitoring and reassessing the decision over time as added information becomes available.
Neither choice is inherently right or wrong. What matters is that the decision reflects an understanding of the potential benefits and downsides, and that it feels appropriate given the current information and personal priorities.
Revisiting the decision over time is also reasonable. As health status, test results, or personal preferences change, so too can the decision about biopsy.
Shared Decision-Making at the Center
At its best, the biopsy decision is made through shared decision-making between a patient and their medical team. This approach recognizes that medical evidence and personal values are both essential.
An informed decision is one that:
- Uses the best available scientific information
- Considers individual health and clinical factors
- Respects personal preferences and tolerance for uncertainty
Taking time to ask questions, reflect, and discuss options is not a delay—it is part of good care.
Moving Forward Thoughtfully
Reaching the biopsy decision does not mean a single path lies ahead. Whether you choose to proceed with biopsy now, monitor and reassess later, or seek additional discussion with your medical team, the goal remains the same: to make choices that are informed, deliberate, and aligned with what matters most to you.
Better information supports better decisions—not rushed ones.